Free Trial

Rapt Therapeutics (RAPT) SEC Filings & 10K Form

Rapt Therapeutics logo
$8.12 +0.12 (+1.44%)
Closing price 07/3/2025 01:04 PM Eastern
Extended Trading
$7.54 -0.59 (-7.26%)
As of 07/3/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Rapt Therapeutics SEC Filings

DateFilerForm TypeView
06/30/2025
7:41 PM
Dombkowski Ashley L. (Reporting)
Rapt Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/30/2025
7:43 PM
Dombkowski Ashley L. (Reporting)
Rapt Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:23 PM
Braunstein Scott (Reporting)
Rapt Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2025
3:25 PM
Braunstein Scott (Reporting)
Rapt Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
7:10 AM
Rapt Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2025
7:11 AM
Rapt Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/09/2025
3:20 PM
Rapt Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
4:02 PM
Lyons-Williams Lori (Reporting)
Rapt Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
4:04 PM
GRAY MARY ANN (Reporting)
Rapt Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
4:06 PM
Giordano Michael F (Reporting)
Rapt Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
3:30 PM
Rapt Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
7:00 AM
Rapt Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G
05/08/2025
7:05 AM
Rapt Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:07 AM
Rapt Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2025
5:35 PM
BlackRock, Inc. (Filed by)
Rapt Therapeutics (Subject)
Form SCHEDULE 13G/A
04/14/2025
7:35 AM
Rapt Therapeutics (Filer)
Form DEF 14A
04/14/2025
7:38 AM
Rapt Therapeutics (Filer)
Form DEFA14A
04/04/2025
4:04 PM
Rapt Therapeutics (Filer)
Form PRE 14A
04/02/2025
8:08 PM
Rapt Therapeutics (Issuer)
Robbins Wendye (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:40 PM
GRAY MARY ANN (Reporting)
Rapt Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
8:04 AM
Rapt Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2025
7:05 AM
Rapt Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
7:07 AM
Rapt Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
7:02 PM
Rapt Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
4:31 PM
Rapt Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
4:31 PM
Rapt Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:23 AM
FMR LLC (Filed by)
Rapt Therapeutics (Subject)
Form SCHEDULE 13G/A
02/03/2025
5:22 PM
Rapt Therapeutics (Issuer)
Wong Brian Russell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:23 PM
Brockstedt Dirk G. (Reporting)
Rapt Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:24 PM
Rapt Therapeutics (Issuer)
Young Rodney KB (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:26 PM
HO WILLIAM (Reporting)
Rapt Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
6:35 AM
Rapt Therapeutics (Filer)
Form 424B3
01/27/2025
11:15 PM
Rapt Therapeutics (Filer)
Form EFFECT
01/21/2025
3:58 PM
Rapt Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/13/2025
3:17 PM
Rapt Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
5:38 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Rapt Therapeutics (Subject)
Form SCHEDULE 13G
01/06/2025
8:22 AM
Medicxi IV LP (Filed by)
Rapt Therapeutics (Subject)
Form SCHEDULE 13G
01/06/2025
8:12 AM
Medicxi Co-Invest IV LP (Reporting)
Medicxi IV GP Ltd (Reporting)
Medicxi IV LP (Reporting)
Medicxi Ventures Management Ltd (0001715579) (Reporting)
Rapt Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2025
1:08 PM
Rapt Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/30/2024
2:32 PM
Foresite Capital Fund VI LP (Filed by)
Rapt Therapeutics (Subject)
Form SCHEDULE 13G
12/23/2024
7:20 PM
COLUMN GROUP II, LP (Filed by)
Rapt Therapeutics (Subject)
Form SCHEDULE 13D/A
Banks aren’t ready for this altcoin—are you? (Ad)

The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.

Discover the protocol that crypto whales are secretly accumulating...
12/23/2024
4:57 PM
Column Group II GP, LP (Reporting)
COLUMN GROUP II, LP (Reporting)
Column Group LLC (Reporting)
GOEDDEL DAVID V (Reporting)
Kutzkey Tim (Reporting)
Ponoi Capital II, LP (Reporting)
PONOI CAPITAL, LP (Reporting)
Ponoi II Management, LLC (Reporting)
Ponoi Management, LLC (Reporting)
Rapt Therapeutics (Issuer)
Svennilson Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
4:59 PM
COLUMN GROUP II, LP (Reporting)
Column Group IV GP, LP (Reporting)
Column Group IV, LP (Reporting)
Column Group IV-A, LP (Reporting)
Rapt Therapeutics (Issuer)
TCG IV GP, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:55 PM
Rapt Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
3:42 PM
Deep Track Capital, LP (Filed by)
Rapt Therapeutics (Subject)
Form SCHEDULE 13G
12/23/2024
6:16 AM
Rapt Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
7:00 PM
Brockstedt Dirk G. (Reporting)
Rapt Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
7:00 PM
HO WILLIAM (Reporting)
Rapt Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
7:00 PM
Rapt Therapeutics (Issuer)
Wong Brian Russell (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
7:00 PM
Rapt Therapeutics (Issuer)
Young Rodney KB (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:15 PM
Rapt Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:39 AM
Deep Track Capital, LP (Filed by)
Rapt Therapeutics (Subject)
Form SC 13G/A
11/12/2024
3:59 PM
Rapt Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
9:34 AM
FMR LLC (Filed by)
Rapt Therapeutics (Subject)
Form SC 13G/A
11/04/2024
12:30 PM
Rapt Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
08/08/2024
7:05 AM
Rapt Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:10 AM
Rapt Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2024
4:24 PM
Rapt Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RAPT) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners